Akron Molecules AG

Akron Molecules is a clinical-stage biotech company dedicated to the discovery and development of novel therapeutics for the treatment of human diseases with unmet medical need, including pain and metabolic disease. Akron Molecules has developed a "drug repurposing" strategy to identify new uses for existing compounds, based on world-class research. By focusing on the repositioning of compounds with known pharmacological profiles to treat new indications, Akron Molecules aims to significantly reduce the time, cost and risk associated with drug development.